The antipsychotic agent flupentixol is a new PI3K inhibitor and potential anticancer drug for lung cancer

Chao Dong(CRRC (China)), Marie C.M. Lin(Zhengzhou University)

International Journal of Biological Sciences

January 1, 2019

10.7150/ijbs.32625

Cited by 35

Related Papers

Analysis of MiR-195 and MiR-497 Expression, Regulation and Role in Breast Cancer

|Clinical Cancer Research|2011|338

CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1

|Oncogene|2022|314

In Silico Identification and In Vitro and In Vivo Validation of Anti-Psychotic Drug Fluspirilene as a Potential CDK2 Inhibitor and a Candidate Anti-Cancer Drug

|PLoS ONE|2015|85

Adapalene inhibits the activity of cyclin-dependent kinase 2 in colorectal carcinoma

|Molecular Medicine Reports|2015|63

Loss of NDUFS1 promotes gastric cancer progression by activating the mitochondrial ROS-HIF1α-FBLN5 signaling pathway

|British Journal of Cancer|2023|49